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> 0.05, ANOVA). Postmortem evaluation
revealed that 2-3 hepatic veins were
transected by injury type 1, 1-2 portal vein
branches plus 1 hepatic vein were transected
by injury type 3 (LLL transection).
Conclusions: The hemorrhage severity of the 
central stellate injury was inadequate, while 
hemorrhage from excision of a proximal 
branch of the portal vein appeared to be too 
severe (i.e., the subjects died too quickly). 
Near-transection of the hepatic LLL at its base 
appeared to yield hemorrhage of appropriate 
severity, as indicated by the 40% 1-hour 
mortality and intermediate values for MAP, 
blood loss, and other variables. Our plan is to 
use this latter injury model in the development 
of therapies for noncompressible truncal 
hemorrhage. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.047
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Exogenous Testosterone Supplementation as Cause of Ischemic Stroke, Mediated through 
Secondary Erythrocytosis
Fuad-al Ali, Amy Hellman, Pierre Fayad
Mentor: Pierre Fayad
Program: Neurology
Background: The use of exogenous 
testosterone has become more prevalent in 
recent years but the effects of such use in 
regards to potential cerebrovascular disease 
have yet to come to a conclusion. In this case 
report, we discuss a patient who suffered 
an ischemic stroke due to testosterone 
supplementation.
Case presentation: A middle-aged 
patient with history of hypertension and 
hyperlipidemia that presented with falls, 
difficulty performing simple tasks and slurred 
speech. Patient had been taking testosterone 
injections every 6 months for the prior 2 years 
for loss of energy and reported low levels. 
Lab work revealed a hemoglobin of 20 g/dL 
and a hematocrit of 51.5%. MRI of the brain 
showed a left striatocapsular ischemic infarct. 
He was given the diagnosis of ischemic stroke 
due to polycythemia and thrombus formation 
secondary to testosterone supplementation. 
Discussion: Testosterone and 
dihydrotestosterone (DHT) has both 
protective and adverse effects. Both low and 
high levels of testosterone and DHT have an 
association with ischemic stroke and there 
may be an optimal level that is safe. 
Conclusion: The risk of ischemic stroke may 
be related to testosterone and DHT levels but 
no clear guidelines exist on optimal levels 
in supplementation. Thus, clinicians should 
be aware of the potential risk and monitor 
androgen and hematocrit levels. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.048
Pharmacological Treatment of Status Epilepticus at UNMC: Assessment of Seizure Outcomes 
Hae Young Baang, Nicholas Swingle, Kalyan Sajja, Deepak Madhavan, Olga Taraschenko
Mentor: Olga Taraschenko
Program: Neurology
Objective: To assess the effectiveness of 
treatment for status epilepticus (SE) at UNMC 
and determine patient health outcomes related 
to the delayed control of seizures 
Design/Methods: Retrospective chart 
review was performed on 1565 adult 
patients who underwent continuous video 
electroencephalography (cvEEG) for 
suspected seizures between January 1, 2012 
and February 28, 2018. 
Results: 49 patients had and were treated for 
64 incidences of convulsive or nonconvulsive 
SE recorded on cvEEG or clinical seizures 
longer than 5 min which were documented by 
a neurologist. Among 64 cases, 55 incidences 
required the second AED treatment, and 
40 out of 55 cases were treated with the 
third AED subsequently. The mean seizure 
detection-to-needle time for the first, 
second, and third antiepileptic drugs were 
167, 239, and 297 minutes, respectively. 
Benzodiazepines were administered as the 
first AED in only 46 % of all treated cases. 
The duration of the hospital stays in patients 
treated with the first AED within 60 min after 
seizure detection was shorter compared to 
those whose treatment was delayed (23.0 vs. 
33.6 days, p=0.41). The mortality rate in the 
former group was lower than that in the group 
which did not receive AEDs within 60 min 
(28.6 vs. 53.6%, p=0.02). 
Conclusion: The current treatment approaches 
for SE at UNMC are inefficient with 
significant delay in delivery of medications 
after seizure detection; they may contribute 
to the prolonged hospital stay and increased 
mortality. In order to improve patient care, the 
existing protocol for the treatment of SE at 
UNMC must be revised. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.049
A Clinical and Cost Effectiveness Comparison of Traditional VNS Therapy to Aspire Sr (106)
Krishna Mourya Galla, Kalyan Sajja, Christopher Wichman, Hongmei Wang, Deepak Madhavan
Mentor: Deepak Madhavan
Program: Neurology
Background: VNS Therapy has demonstrated 
overall cost savings in patients with drug-
51 
resistant epilepsy. The overall goal of this 
project is to evaluate the clinical and cost 
effectiveness of the Aspire SR 106 VNS 
(Vagus Nerve Stimulator) system, using 
retrospective patient data. We anticipate 
the extra dimension of closed-loop 
autostimulation in the Aspire 106 model will 
demonstrate more efficient utilization of 
health care resources. 
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Methods: Data were collected using 
EPIC® starting 12 months prior to VNS 
replacement to Aspire ® device to 12 months 
after implantation date in 3-month blocks. 
Seizure frequency before and after the VNS 
implantation as well as medication changes 
were identified from review of clinic notes. 
Cost was estimated based on the number 
of visits for ER, clinic, hospital, and ICU 
using hospital average cost data. As cost 
distributions are skewed to the right, we also 
calculated log total costs for the trend analysis 
using segmented model. For data analysis 
segmented Poisson regression was used to 
establish a trend in usage per quarter.
Results: The trend in Clinic usage was 
statistically flat (p > 0.05) in the pre-
placement period while the trend in the post 
placement was downward with an estimate 
that for every quarter the natural log of the 
average number of clinic visits decreases by 
0.29. By one-year post placement, the average 
number of clinic visits had achieved the same 
level as the pre-placement period. The trends 
in ER and hospital usage were flat in both the 
pre and post placement periods. The median 
number of CPS in the year after placement of 
the Aspire 106 VNS was statistically smaller 
by 1 (p = 0.0161) CPS than the median 
number of CPS in the year prior to placement. 
Conclusion: Analysis of the above data 
yielded two main findings: there were no 
demonstrable cost savings within a 12-month 
period following VNS implantation, but the 
median burden of Complex Partial Seizures 
(CPS) within our cohort revealed a 50% 
decline, which was statistically significant. 
However, overall costs post-implantation 
showed a consistent downward trajectory, 
with approximation to pre-implantation costs 
within the 12-month timeframe.
https://doi.org/10.32873/unmc.dc.gmerj.1.1.050
Diplopia and Vertical Gaze Palsy with Punctate Brain Stem Infarct
Jamison Hofer, Sachin Kedar, T. Scott Diesin, Daniel Zhou, Nicholas Swingle
Mentor: Sachin Kedar
Program: Neurology
Objective: To describe the clinical features, 
MRI findings, and neuroanatomy of a patient 
with a punctate brainstem stroke.
Method: Characterize the eye movement 
deficits in this patient and correlate the MRI 
diffusion restriction findings.
Results: This patient presented with vertical 
gaze palsy and impaired adduction of the 
left eye. Impaired smooth pursuits up and 
down clinically localized to damage in the 
interstitial nucleus of Cajal. Impaired saccades 
up and down localized to the rostral interstitial 
nuclei of the medial longitudinal fasciculus. 
MRI showed diffusion restriction in the left 
thalamus-midbrain junction just posterior to 
the red nucleus.
Conclusion: This case illustrates how a 
punctate single unilateral lesion can present 
with vertical supranuclear gaze palsy and 
horizontal eye movement abnormalities. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.051
Paroxysmal Autonomic Instability and Dystonia Following a Motor Vehicle Accident
Matthew Purbaugh, Krishna Galla, Marco A. Gonzalez Castellon
Mentor: Marco A. Gonzalez Castellon
Program: Neurology
Background: We were consulted a young 
adult patient who presented following a motor 
vehicle accident. The patient presented with 
diffuse axonal injury, hemorrhage of left basal 
ganglia increased intra-cranial pressure and 
other injuries. The patient was intubated, an 
intraventricular shunt had been removed and 
a 7-day course of Keppra prophylaxis had 
been finished. The patient was stable until the 
morning we were consulted. 
Methods: On exam the patient had episodes 
of extensor posturing, diffuse dystonia and 
high frequency, low amplitude tremors, with 
autonomic instability limited to these spells. 
The patient was found to have 3+ reflexes 
throughout. Brain stem reflexes were intact. 
Stimuli caused extensor posturing, rigidity 
and autonomic instability. Continuous VEEG 
showed epileptiform activity that did not 
correlate with spells on video. Lab was 
non-specific expect for a reelevated CK. We 
loaded Keppra and prn diazepam. This failed 
to control the symptoms.
Results: We arrived at a diagnosis of 
paroxysmal autonomic instability and 
dystonia (PAID) syndrome. Treatment with 
clonazepam, Gabapentin, baclofen and 
propranolol stabilized the autonomic system 
and resolved the dystonia. The CK began 
to drop and the patient began to respond to 
commands. 
Conclusions: PAID most commonly 
affects young persons following severe 
TBI. Potentially caused by disinhibition 
of sympathoexcitatory regions leading to 
cortically provoked catecholamine surges 
causing autonomic instability. Dystonia 
is secondary to disruption of the pontine 
and vestibular nuclei. PAID should on the 
differential diagnosis of TBI patients who 
are not responding to typical treatments. 
We had success treating with Clonazepam, 
gabapentin, baclofen and propranolol.  
https://doi.org/10.32873/unmc.dc.gmerj.1.1.052
Diagnostic Challenges in The Radiographic Distinction Between Demyelinating Lesions and 
Primary Brain Neoplasms
Erin L. Smith and Geetanjali Rathore
Mentor: Geetanjali Rathore
Program: Neurology
Introduction: The differentiation between 
demyelinating lesions and primary brain 
neoplasms is difficult based on radiography 
alone, resulting in misdiagnoses and delay 
in treatment. Here we present two cases 
with MRI abnormalities suggestive of either 
demyelination or neoplasm. Case 1 was 
treated with steroids for a demyelinating 
process, but was found on biopsy to have an 
anaplastic astrocytoma that was unresectable 
by the time of diagnosis. Case 2 was thought 
to be glioma but was later determined to be 
tumefactive demyelination. In both cases, 
there were delays due to the limitations of MR 
imaging.  
Methods: The cases of the two patients 
were reviewed via EMR. A literature review 
investigated the most sensitive and specific 
non-invasive diagnostic modalities for 
diagnosing demyelinating lesions or primary 
brain neoplasms. 
 Results: Review of recent literature shows 
that conventional MR sequences have 
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